TBPH – theravance biopharma, inc. - ordinary shares (US:NASDAQ)
Stock Stats
News
TBPH Investors Have Opportunity to Join Theravance Biopharma, Inc. Fraud Investigation with the Schall Law Firm
Theravance Biopharma (TBPH) had its price target raised by B. Riley Financial, Inc. from $14.00 to $17.00. They now have a "neutral" rating on the stock.
Theravance Biopharma (TBPH) was downgraded by Wall Street Zen from "s
TBPH Investors Have Opportunity to Join Theravance Biopharma, Inc. Fraud Investigation with the Schall Law Firm
TBPH: Reported $22M in Operating Expenses While Advancing Trial Enrollment -- LEVI & KORSINSKY, LLP Investigates
Form 4 Theravance Biopharma, For: Apr 01 Filed by: Winningham Rick E
Form 4 Theravance Biopharma, For: Apr 01 Filed by: Sawaf Aziz
Form 4 Theravance Biopharma, For: Apr 01 Filed by: Grimaud Brett A.
Form 4 Theravance Biopharma, For: Apr 01 Filed by: Farnum Rhonda
Form 8-K Theravance Biopharma, For: Mar 27
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.